Skip to main content
Livermore
Livermore
ZHEN

Headinvest, LLC

SEC CIK
0001372130
Latest filing
Aug 14, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Headinvest, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
88,590
Value
$4.25M
% of portfolio
0.8%
Quarters held
22
Since Q1 2021
Holdings of NVO by Headinvest, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202688,590$4.25M0.8%−4,478−4.8%ReducedHolders
Q1 202693,068$3.42M0.7%−12,680−12.0%ReducedHolders
Q4 2025105,748$5.38M1.1%−7,316−6.5%ReducedHolders
Q3 2025113,064$6.27M1.3%−3,925−3.4%ReducedHolders
Q2 2025116,989$8.07M1.7%+3,013+2.6%AddedHolders
Q1 2025113,976$7.91M1.5%−2,251−1.9%ReducedHolders
Q4 2024116,227$10.0M1.9%−3,520−2.9%ReducedHolders
Q3 2024119,747$14.3M2.6%−4,875−3.9%ReducedHolders
Q2 2024124,622$17.8M3.5%−4,110−3.2%ReducedHolders
Q1 2024128,732$16.5M3.2%−7,879−5.8%ReducedHolders
Q4 2023136,611$14.1M2.9%−2,407−1.7%ReducedHolders
Q3 2023139,018$12.8M2.8%−1,220−0.9%ReducedConverted for a 2-for-1 splitHolders
Q2 202370,119$12.7M2.7%−6,192−8.1%ReducedHolders
Q1 202376,311$12.1M2.7%−7,277−8.7%ReducedHolders
Q4 202283,588$11.3M2.5%−2,723−3.2%ReducedHolders
Q3 202286,311$8.60M2.1%−1,455−1.7%ReducedHolders
Q2 202287,766$9.78M2.2%−1,362−1.5%ReducedHolders
Q1 202289,128$9.90M1.9%−1,667−1.8%ReducedHolders
Q4 202190,795$10.2M1.8%−3,052−3.3%ReducedHolders
Q3 202193,847$9.01M1.7%−859−0.9%ReducedHolders
Q2 202194,706$7.93M1.5%−343−0.4%ReducedHolders
Q1 202195,049$6.41M1.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.